Resurgence of tuberculosis and the impact of HIV infection

British Medical Bulletin

Volumn 54, Issue 3, 1998, Pages 579-593

  Glynn, Judith R ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

DISEASE TRANSMISSION; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; INFECTION RISK; MYCOBACTERIUM TUBERCULOSIS; POVERTY; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 0031751262     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011712     Document Type: Review

References (87)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994; 72: 213-20
2. Cantwell MF, Snider Jr DE, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272: 535-9
3. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in Western Europe. Bull World Health Organ 1993; 71: 297-306
4. Raviglione MC, Rieder HL, Styblo K, Khomenko AG, Esteves K, Kochi A. Tuberculosis trends in Eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75: 400-16
5. Pehme L, Sillatsu H, Danilovits M, Kurve A. Tuberculosis mortality in Estonia in 1996-1996. Int Tuberc Lung Dis 1997; 1: S94
6. Drobniewski F, Tayler E, Ignatenko N et al. Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment. Tubercle Lung Dis 1996; 77: 199-206
7. Aksenova V, Senkina T, Sevostianova T. Epidemiology of tuberculosis in children in the Russian Federation in 1996. Int J Tuberc Lung Dis 1997; 1: S152
8. Cantwell MF, Binkin NJ. Tuberculosis in sub-Saharan Africa: a regional assessment of the impact of the human immunodeficiency virus and National Tuberculosis Control Program quality. Tubercle Lung Dis 1996; 77: 220-5
9. Raviglione MC, Snider Jr DE, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-6
10. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24
11. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991; 72: 1-6
12. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996; 347: 358-62
13. Rieder HL. Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tubercle Lung Dis 1995; 76: 114-21
14. Kaye K, Frieden TR. Tuberculosis control: the relevance of classic principles in an era of acquired immune deficiency syndrome and multidrug resistance. Epidemiol Rev 1996; 18: 52-63
15. Vynnycky E, Fine PEM. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997; 119: 183-201
16. Lucas SB, De Cock KM, Hounnou A et al. Contribution of tuberculosis to slim disease in Africa. BMJ 1994; 308: 1531-3
17. Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PEW, Veen J, van Embden JDA. Analysis of tuberculosis transmission between nationalities in The Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol 1998; 147: 187-95
18. Farmer P. Social inequalities and emerging infectious diseases. Emerg Infect Dis 1996; 2: 259-69
19. Zolopa AR, Hahn JA, Gorter R et al. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA 1994; 272: 455-61
20. Nardell E, McInnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med 1986; 315: 1570-5
21. Kochi A. Tuberculosis: distribution, risk factors, mortality. Immunobiology 1994; 191: 325-36
22. Vail Mayans M, Maguire A, Mirret M, Alcaide J, Parron I, Casabona J. The spread of AIDS and the re-emergence of tuberculosis in Catalonia, Spain. AIDS 1997; 11: 499-505
23. Ferreira MM, Ferrazoli L, PaJaci M et al. Tuberculosis and HIV infection among female inmates in Sao Paulo, Brazil: a prospective cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 177-83
24. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-9
25. Datta M, Radhamani MP, Selvaraj R et al. Critical assessment of smear-positive tuberculosis patients after chemotherapy under the district tuberculosis programme. Tubercle Lung Dis 1993; 74: 180-6
26. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997; 24: S121-30
27. Gourevirch MN, Harrel D, Schoenbaum EE, Klein RS. Lack of association of induration size with HIV infection among drug users reacting to tuberculin. Am J Respir Crit Care Med 1996; 154: 1029-33
28. Chin DP, Osmond D, Page-Shafer K et al. Reliability of anergy skin testing in persons with HIV infection. Am J Respir Crit Care Med 1996; 153; 1982-4
29. Leroy V, Msellati P, Lepage P et al. Four years of natural history of HIV-1 infection in African women: a prospective cohort study in Kigali (Rwanda), 198S-1993. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 415-21
30. Allen S, Batungwanayo J, Kerlikowske K et al. Two-year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992; 146: 1439-44
31. Braun MM, Badi N, Ryder RW et al. A retrospective cohort study of the risk of TB among women of childbearing age with HIV infection in Zaire. Am Rev Respir Dis 1991; 143: 501-4
32. Selwyn PA, Sckell B, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 1992; 268: 504-9
33. Keizer ST, Langendam MW, van Deutekom H, Coutinho RA, van Ameijden EJC. Tuberculosis and HIV-infection in a cohort of drug users, Amsterdam 1986-1995. Int J Tuberc Lung Dis 1997; 1: 5157-8
34. Van den Broek J, Borgdorff MW, Pakker NG et al. HIV-1 infection as a risk factor for the development of tuberculosis: a case-control study in Tanzania. Int J Epidemiol 1993; 22: 1159-65
35. Naucler A, Winqvist N, Dias F et al. Pulmonary tuberculosis in Guinea-Bissau; clinical and bacteriological findings, human immunodeficiency virus status and short term survival of hospitalized patients. Tubercle Lung Dis 1996; 77: 226-32
36. Orege PA, Fine PEM, Lucas SB et al. A case control study on human immunodeficiency virus-1 (HIV-1) infection as a risk factor for tuberculosis and leprosy in Western Kenya. Tubercle Lung Dis 1993; 74: 377-81
37. Pönnighaus JM, Mwanjasi LJ, Fine PEM et al. Is HIV infection a risk factor for leprosy? Int J Lepr 1991; 59: 221-8
38. Glynn JR, Warndorff DK, Fine PEM, Msiska GK, Munthali MM, Pönnighaus JM. The impact of HIV on morbidity and mortality from tuberculosis in sub-Saharan Africa: a study in rural Malawi and review of the literature. Health Transition Rev 1997; 7(Suppl 2): 75-87
39. Selwyn PA, Hartel D, Lewis VA et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-50
40. Gilks CF, Godfrey-Faussett P, Batchelor BIF et al. Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya. AIDS 1997; 11: 911-8
41. Long R, Scalcini M, Manfreda J et al. Impact of HIV type I on tuberculosis in rural Haiti. Am Rev Respir Dis 1991; 143: 69-73
42. Gilks CF, Brindle RJ, Otieno LS et al. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS 1990; 4: 981-5
43. De Cock KM, Gnaore E, Adjorlolo G et al. Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast. BMJ 1991; 302: 496-9
44. Chum HJ, O'Brien RJ, Chonde TM, Graf P, Rieder HL. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. AIDS 1996; 10: 299-309
45. Van Cleef MRA, Chum HJ. The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus. Int J Epidemiol 1995; 24: 637-42
46. Migliori GB, Borghesi A, Adriko C et al. Tuberculosis and HIV infection association in a rural district of Northern Uganda: epidemiological and clinical considerations. Tubercle Lung Dis 1992; 73: 285-90
47. Houston S, Ray S, Mahari M et al. The association of tuberculosis and HIV infection in Harare, Zimbabwe. Tubercle Lung Dis 1994; 75: 220-6
48. Antonucci G, Girardi E, Raviglione MC, Ippolito G. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995; 274: 143-8
49. Pape J, Jean SS, Ho JL, Hafner A, Johnson WD. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993; 342: 268-72
50. Rubinstien EM, Madden GM, Lyons RW. Active tuberculosis in HIV-infected injecting drug users from a low-rate tuberculosis area. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 11: 448-54
51. Markowitz N, Hansen NI, Hopewell PC et al. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997; 126: 123-32
52. Moreno S, Baraia-Etxaburu J, Bouza E et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med 1993; 119: 194-8
53. Moreno S, Miralles P, Diaz MD et al. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long term effect on development of tuberculosis and survival. Arch Intern Med 1997; 157: 1729-34
54. Guelar A, Gatell JM, Verdejo J et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-9
55. Girardi E, Antonucci G, Ippolito G et al. Association of tuberculosis risk with the degree of tuberculin reaction in HIV-infected patients. The Gruppo Italiano di Studio Tubercplosi e AIDS. Arch Intern Med 1997; 157: 797-800
56. Hawken MP, Meme HK, Elliott LC et al. Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial, AIDS 1997; 11: 875-82
57. Whalerr CC, Johnson JL, Okwera A et al. A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 801-8
58. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055-64
59. Couldwell DL, Dore GJ, Harkness JL et al. Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room. AIDS 1996; 10: 521-5
60. Daley CL, Small PM, Schecter GF et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1993; 326: 231-5
61. Di Perri G, Cruciani M, Danzi MC et al. Nosocomial epidemic of active tuberculosis among HIV-infecred patients. Lancet 1989; 2: 1502-4
62. Hyge TV. The efficacy of BCG-vaccination. Epidemic of tuberculosis in a State School with an observation period of 12 years. Acta Tuberculosea 1955; 32: 89-107
63. Raffali J, Sepkowitz KA, Armstrong D. Community-based outbreaks of tuberculosis. Arch Intern Med 1996; 156; 1053-60
64. Small PM, Hopewell PC, Singh SP et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-9
65. Alland D, Kalkut GE, Moss AR et al. Transmission of Tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-6
66. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SW. The molecular epidemiology of tuberculosis in New York City; the importance of nosocomial transmission and laboratory error. Tubercle Lung Dis 1996; 77: 407-13
67. Wilkinson D, Pillay M, Crump J, Lombard C, Davies GR, Sturm AW. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa. Trop Med Int Health 1997; 2: 747-53
68. Warren R, Hauman J, Beyers N et al. Unexpectedly high strain diversity of Mycobacterium tuberculosis in a high incidence community. S Afr Med J 1996; 86: 45-9
69. Glynn JR, Vynnycky E, Fine PEM. The influence of sampling on estimates of recent transmission of M. tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1998; In press
70. Samper S, Iglesias MJ, Rabanaque MJ et al. Retrospective RFLP-population-based study of tuberculosis in Zaragoza (Spain). Combined meeting of the Concerted Actions on Tuberculosis, Cordoba 1997; A8
71. Di Perri G, Cadeo GP, Castelli F et al. Transmission of HIV-associated tuberculosis to health care workers. Lancet 1992; 340: 682
72. Nunn P, Mungai M, Nyamwaya J et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tubercle Lung Dis 1994; 75: 25-32
73. Klausner JD, Ryder RW, Baende E et al. Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1-seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire. J Infect Dis 1993; 168: 106-11
74. Elliott AM, Hayes RJ, Halwiindi B et al. The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia. AIDS 1993; 7: 981-7
75. Cauthen GM, Dooley SW, Onorato IM et al. Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS. Am J Epidemiol 1996; 144: 69-77
76. Carvalho ACC, Figueira MM, Brito Z et al. Tuberculosis transmission from pulmonary tuberculosis patients (PTP) infected by HIV in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 1997; 1: S159
77. Bermejo A, Veeken H, Berra A. Tuberculosis incidence in developing countries with high prevalence of HIV infection. AIDS 1992; 6: 1203-6
78. Richards SB, St Louis ME, Nieburg P et al. Impact of the HIV epidemic on trends in tuberculosis in Abidjan, Cote d'Ivoire. Tubercle Lung Dis 1995; 76: 11-6
79. Lienhardt C, Rodrigues LC. The estimation of the impact of HIV infection on tuberculosis: tuberculosis risks re-visited? Int J Tuberc Lung Dis 1997; 1: 196-204
80. Heymann SJ. Modelling the efficacy of prophylactic and curative therapies for preventing the spread of tuberculosis in Africa. Trans R Soc Trop Med Hyg 1993; 87: 406-11
81. Schulzer M, Radhamani MP, Grzybowski S, Mak E, Fitzgerald JM. A mathematical model for the prediction of the impact of HIV infection on tuberculosis, Int J Epidemiol 1994; 23: 400-7
82. Brewer TF, Heymann SJ, Colditz GA et al. Evaluation of tuberculosis control policies using computer simulation. JAMA 1996; 276: 1898-903
83. Borgdorff MW, Kiambih FM, Odhiambo JA et al. Comparison between districts in the analysis of national tuberculin surveys: an example in Kenya. International Union Against Tuberculosis and Lung Disease, Conference Abstract 1997
84. Narain JP, Raviglione MC, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-21
85. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995; 346: 1339-45
86. Tuberculosis preventive therapy in HIV-infectcd individuals. A joint statement of the International Union Against Tuberculosis and Lung Disease (IUATLD) and the Global Programme on AIDS and the Tuberculosis Programme of the World Health Organization (WHO). Tubercle Lung Dis 1994; 75: 96-8
87. Kornbluth RS, McCutchan JA. Skin test responses as predictors of tuberculous infection and of progression in HIV-infected persons. Ann Intern Med 1993; 119: 241-3